Found: 22
Select item for more details and to access through your institution.
Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer?
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 9, p. 757, doi. 10.1007/s40261-021-01070-1
- By:
- Publication type:
- Article
IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment.
- Published in:
- Molecular Diagnosis & Therapy, 2021, v. 25, n. 4, p. 457, doi. 10.1007/s40291-021-00537-3
- By:
- Publication type:
- Article
Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 491, doi. 10.1007/s40265-022-01702-6
- By:
- Publication type:
- Article
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
- Published in:
- Acta Neuropathologica, 2021, v. 141, n. 6, p. 945, doi. 10.1007/s00401-021-02291-6
- By:
- Publication type:
- Article
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 165, doi. 10.1007/s12325-021-01977-3
- By:
- Publication type:
- Article
Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 865, doi. 10.1002/onco.13858
- By:
- Publication type:
- Article
Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 10, p. 1852, doi. 10.3390/diagnostics11101852
- By:
- Publication type:
- Article
Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. Diagnostics 2020, 10 , 265.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
IDH1 Non-Canonical Mutations and Survival in Patients with Glioma.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 2, p. 342, doi. 10.3390/diagnostics11020342
- By:
- Publication type:
- Article
miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 5, p. 265, doi. 10.3390/diagnostics10050265
- By:
- Publication type:
- Article
Assessment of <i>EGFR</i> Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0103883
- By:
- Publication type:
- Article
Temozolomide in Patients with High Grade Gliomas.
- Published in:
- Oncology, 2000, v. 59, n. 3, p. 181, doi. 10.1159/000012158
- By:
- Publication type:
- Article
Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3205, doi. 10.3390/biomedicines10123205
- By:
- Publication type:
- Article
Tumor-Associated Microenvironment of Adult Gliomas: A Review.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.891543
- By:
- Publication type:
- Article
Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.852950
- By:
- Publication type:
- Article
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 333, doi. 10.3390/cancers14020333
- By:
- Publication type:
- Article
Glioblastoma: Emerging Treatments and Novel Trial Designs.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3750, doi. 10.3390/cancers13153750
- By:
- Publication type:
- Article
A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 264, doi. 10.1093/neuonc/noaa156
- By:
- Publication type:
- Article
A PHASE III RANDOMIZED CONTROLLED TRIAL OF SHORT-COURSE RADIOTHERAPY WITH OR WITHOUT CONCOMITANT AND ADJUVANT TEMOZOLOMIDE IN ELDERLY PATIENTS WITH GLIOBLASTOMA (NCIC CTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677).
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii46
- By:
- Publication type:
- Article
Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy: A phase II study.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 9, p. 2079
- By:
- Publication type:
- Article
A multicenter study of the prognosis and treatment of adult brain ependymal tumors.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 6, p. 1221
- By:
- Publication type:
- Article